Formulations of morphine sulphate are easily confusedBMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7058.687b (Published 14 September 1996) Cite this as: BMJ 1996;313:687
- Gillian F Cavell, Principal pharmacist
- King's College Hospital, London SE5 9RS
EDITOR,—The recommendations for the use of morphine in cancer pain produced by the Expert Working Group of the European Association for Palliative Care provide a comprehensive framework that will be of benefit to all health care professionals caring for this group of patients.1 Prescribing morphine sulphate may, however, give rise to problems. The current edition of the British National Formulary lists several proprietary oral preparations of morphine sulphate, including liquid, sustained release, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial